Ignite Creation Date:
2024-05-06 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05031546
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-05-18
First Post:
2021-08-26
Brief Title:
Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2021-08-26
First Submit QC Date:
August 26 2021
Study First Post Date:
2021-09-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-11
Last Update Post Date:
2022-05-18
Last Update Post Date Type:
ACTUAL